摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-propyl-4-phenylphenol | 194792-75-1

中文名称
——
中文别名
——
英文名称
2-propyl-4-phenylphenol
英文别名
4-hydroxy-3-propyl-biphenyl;4-phenyl-2-propylphenol
2-propyl-4-phenylphenol化学式
CAS
194792-75-1
化学式
C15H16O
mdl
——
分子量
212.291
InChiKey
UIFYLOYBNHJKDV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    332.9±11.0 °C(Predicted)
  • 密度:
    1.048±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-propyl-4-phenylphenolpotassium carbonate 作用下, 以 甲醇N,N-二甲基甲酰胺 为溶剂, 生成
    参考文献:
    名称:
    Aryloxazolidinediones: identification of potent orally active PPAR dual α/γ agonists
    摘要:
    A series of novel aryloxazolidine-2,4-diones was synthesized. A structure-activity relationship study of these compounds led to the identification of potent, orally active PPAR dual alpha/gamma agonists. Based on the results of efficacy studies in the db/db mice model of type 2 diabetes and the desired pharmacokinetic parameters, compound 12 was selected for further profiling. (C) 2003 Published by Elsevier Ltd.
    DOI:
    10.1016/s0960-894x(03)00785-6
  • 作为产物:
    描述:
    1-烯丙氧基-4-氯甲基-苯 在 palladium on activated charcoal 氢气 作用下, 以 甲醇邻二氯苯 为溶剂, 生成 2-propyl-4-phenylphenol
    参考文献:
    名称:
    Aryloxazolidinediones: identification of potent orally active PPAR dual α/γ agonists
    摘要:
    A series of novel aryloxazolidine-2,4-diones was synthesized. A structure-activity relationship study of these compounds led to the identification of potent, orally active PPAR dual alpha/gamma agonists. Based on the results of efficacy studies in the db/db mice model of type 2 diabetes and the desired pharmacokinetic parameters, compound 12 was selected for further profiling. (C) 2003 Published by Elsevier Ltd.
    DOI:
    10.1016/s0960-894x(03)00785-6
点击查看最新优质反应信息

文献信息

  • Hypervalent iodine oxidation of phenol derivatives using a catalytic amount of 4-iodophenoxyacetic acid and Oxone® as a co-oxidant
    作者:Takayuki Yakura、Masanori Omoto、Yû Yamauchi、Yuan Tian、Ayaka Ozono
    DOI:10.1016/j.tet.2010.04.124
    日期:2010.7
    Reaction of p-substituted phenols 2 with a catalytic amount of 4-iodophenoxyacetic acid (1) and Oxone® as a co-oxidant in tetrahydrofuran (THF) or 1,4-dioxane–water gave the corresponding p-quinols 3 in excellent yields. Reaction of p-dialkoxyarenes 4 in 2,2,2-trifluoroethanol–water gave the corresponding p-quinones 5 in excellent yield without purification. These reactions provide efficient and practical
    的反应p取代的酚2用4- iodophenoxyacetic酸(催化剂量1)过硫酸氢钾®如四氢呋喃(THF)的共氧化剂或1,4-二恶烷-水,得到相应的p -quinols 3以优良产率。的反应p -dialkoxyarenes 4在2,2,2-三氟乙醇-水,得到相应的p -quinones 5的优良率,无需纯化。这些反应为由对位取代的苯酚和对位苯甲酸制备对苯二酚和对苯醌提供了有效而实用的方法。-二烷氧基芳烃。该醌合成用于德国小att Blattella germanica的性信息素blattellaquinone(13)的合成。
  • [EN] SYNTHESIS OF TERPHENYL COMPOUNDS<br/>[FR] SYNTHÈSE DE COMPOSÉS TERPHÉNYLE
    申请人:VECTUS BIOSYSTEMS LTD
    公开号:WO2017049343A1
    公开(公告)日:2017-03-30
    The present invention relates novel methods of synthesizing terphenyl compounds and in particular to novel methods for the synthesis of a compound of Formula I or intermediates thereof.
    本发明涉及一种合成三苯基化合物的新方法,特别是用于合成化合物I的新方法或其中间体的方法。
  • Disubstituted biphenyloxazolines
    申请人:Bayer Aktiengesellschaft
    公开号:US06410581B1
    公开(公告)日:2002-06-25
    The present invention relates to novel biphenyloxazolines of the formula (I) in which X1, X2, X3, R1, R2 and R3 are each as defined in the description, to processes for their preparation and to the use of the biphenyloxazolines for controlling animal pests.
    本发明涉及公式(I)中的新型联苯氧唑啉,其中X1、X2、X3、R1、R2和R3的定义如说明书所述,以及它们的制备过程和用于控制动物害虫的联苯氧唑啉的用途。
  • DISUBSTITUTED BIPHENYLOXAZOLINES
    申请人:——
    公开号:US20020086892A1
    公开(公告)日:2002-07-04
    The present invention relates to novel biphenyloxazolines of the formula (I) 1 in which X 1 , X 2 , X 3 , R 1 , R 2 and R 3 are each as defined in the description, to processes for their preparation and to the use of the biphenyloxazolines for controlling animal pests.
    本发明涉及式(I)1的新型联苯氧唑化合物,其中X1、X2、X3、R1、R2和R3的定义详见说明书,以及其制备方法和用于控制动物害虫的应用。
  • PROCESS FOR PRODUCING ISOCYANATES
    申请人:Shinohata Masaaki
    公开号:US20100029981A1
    公开(公告)日:2010-02-04
    An object of the present invention is to provide a process that enables isocyanates to be stably produced over a long period of time at high yield without encountering various problems as found in the prior art when producing isocyanates without using phosgene. The present invention discloses a process for producing an isocyanate, comprising the steps of: reacting a carbamic acid ester and an aromatic hydroxy compound to obtain an aryl carbamate having a group derived from the aromatic hydroxy compound; and subjecting the aryl carbamate to a decomposition reaction, wherein the aromatic hydroxy compound is an aromatic hydroxy compound which is represented by the following formula (1) and which has a substituent R 1 at least one ortho position of a hydroxyl group: (wherein ring A represents an aromatic hydrocarbon ring in a form of a single or multiple rings which may have a substitute and which have 6 to 20 carbon atoms; R 1 represents a group other than a hydrogen atom in a form of an aliphatic alkyl group having 1 to 20 carbon atoms, an aliphatic alkoxy group having 1 to 20 carbon atoms, an aryl group having 6 to 20 carbon atoms, an aryloxy group having 6 to 20 carbon atoms, an aralkyl group having 7 to 20 carbon atoms or an aralkyloxy group having 7 to 20 carbon atoms, the group containing an atom selected from a carbon atom, an oxygen atom and a nitrogen atom; and R 1 may bond with A to form a ring structure).
    本发明的目的是提供一种过程,使得在不使用光气的情况下,能够稳定地高产长时间生产异氰酸酯,而不会遇到生产异氰酸酯时在先前技术中发现的各种问题。本发明公开了一种生产异氰酸酯的方法,包括以下步骤:反应一个氨基甲酸酯和一个芳香羟基化合物以获得含有源自芳香羟基化合物的基团的芳基氨基甲酸酯;并将芳基氨基甲酸酯进行分解反应,其中芳香羟基化合物是由以下式(1)表示并且在羟基位置的至少一个邻位上具有取代基R1的芳香羟基化合物:(其中,环A表示一个具有单个或多个环,并且可能具有取代基的芳香烃环,其具有6至20个碳原子;R1表示除氢原子外的基团,以具有1至20个碳原子的脂肪基烷基团,具有1至20个碳原子的脂肪基烷氧基团,具有6至20个碳原子的芳基团,具有6至20个碳原子的芳氧基团,具有7至20个碳原子的芳基烷基团或具有7至20个碳原子的芳基烷氧基团,该基团含有从碳原子、氧原子和氮原子中选择的原子;并且R1可以与A结合形成一个环状结构)。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐